IP Verse

Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene

Patent No. EP3984538 (titled "Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene") was filed by Amicus Therapeutics on Aug 7, 2020. The application was issued on Nov 5, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERAug 5, 2026BRAND MURRAY FULLER
MAIWALD PATENTANWALTSAug 4, 2026MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
HAMM&WITTKOPP PATENTANWÄLTE PARTMBBAug 3, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
TEVA PHARMACEUTICAL INDUSTRIES LTDJul 20, 2026D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3984538

AMICUS THERAPEUTICS
Application Number
EP21197291A
Filing Date
Aug 7, 2020
Status
Granted And Under Opposition
Oct 3, 2025
Publication Date
Nov 5, 2025
External Links
Slate, Register , Google Patents